Marcelo F. Di Carli

TL;DR: Peter Alagona, JR,MD, FACC* Timothy M. Bateman, MD, F ACC† Manuel D. Cerqueira, MD , FACC, FAHA, FASNC, James R. Kwong, MD*, James Min, MD), FACC†† Miguel A. Quinones, MD-FACC‡‡ R. Parker Ward, MD.

TL;DR: In patients with a prior MI, the extent of the peri-infarct zone characterized by CMR provides incremental prognostic value beyond left ventricular systolic volume index or ejection fraction.

TL;DR: Noninvasive quantitative assessment of coronary vasodilator function with positron emission tomography is a powerful, independent predictor of cardiac mortality in patients with known or suspected coronary artery disease and provides meaningful incremental risk stratification over clinical and gated myocardial perfusion imaging variables.

TL;DR: Initial 320-detector row coronary CT images have consistently excellent quality and iodinated contrast opacification and future work will focus on lowering contrast and radiation dose while maintaining image quality.

TL;DR: The American College of Cardiology Foundation (ACCF) conducted an appropriate use review of common clinical scenarios where cardiac radionuclide imaging (RNI) is frequently considered as mentioned in this paper, which is a revision of the original Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT MPI) Appropriateness Criteria, published 4 years earlier, written to reflect changes in test utilization and new clinical data, and to clarify RNI use where omissions or lack of clarity existed in the original criteria.